The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Vanilloids in pancreatic cancer: potential for chemotherapy and pain management
Open accessAbstract
Background: Success of chemotherapy and alleviation of pain are frequently less than optimal in pancreatic cancer patients, leading to increasing interest in new pharmacological substances, such as vanilloids. Our study addressed the question of whether vanilloids influence pancreatic cancer cell growth, and if vanilloids could be used for pain treatment via the vanilloid 1 receptor (VR1) in pancreatic cancer patients. Methods: In vitro, the effect of resiniferatoxin (vanilloid analogue) on apoptosis and cell growth in pancreatic cancer cells—either alone, combined with 5-fluorouracil (5-FU), or combined with gemcitabine—was determined by annexin V staining, FACS analysis, and MTT assay, respectively. VR1 expression was evaluated on RNA and protein level by quantitative polymerase chain reaction and immunohistochemistry in human pancreatic cancer and chronic pancreatitis. Patient characteristics—especially pain levels—were registered in a prospective database and correlated with VR1 expression. Results: Resiniferatoxin induced apoptosis by targeting mitochondrial respiration and decreased cell growth in pancreatic cancer cells without showing synergistic effects with 5-FU or gemcitabine. Expression of VR1 was significantly upregulated in human pancreatic cancer and chronic pancreatitis. VR1 expression was related to the intensity of pain reported by cancer patients but not to the intensity of pain reported by patients with chronic pancreatitis. Conclusions: Resiniferatoxin induced apoptosis in pancreatic cancer cells indicates that vanilloids may be useful in the treatment of human pancreatic cancer. Furthermore, vanilloid might be a novel and effective treatment option for neurogenic pain in patients with pancreatic cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deletion of vanilloid receptor 1_expressing primary afferent neurons for pain control
Karai, L., Brown, D. C., Mannes, A. J., Connelly, S. T., Brown, J., Gandal, M., Wellisch, O. M., Neubert, J. K., Olah, Z., & Iadarola, M. J. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20449 · Cited by 340
Cited by
Perineural invasion and associated pain in pancreatic cancer
Bapat, A. A., Hostetter, G., Von Hoff, D. D., & Han, H. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3131 · Cited by 501
Biochemistry and pharmacology of endovanilloids
Starowicz, K., Nigam, S., & Di Marzo, V. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.01.005 · Cited by 383
Prevarskaya, N., Zhang, L., & Barritt, G. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2007.05.006 · Cited by 355
Ion channel expression as promising cancer biomarker
Lastraioli, E., Iorio, J., & Arcangeli, A. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.12.016 · Cited by 187
Metadata
- Authors
- Hartel, M., di Mola, F. F., Selvaggi, F., Mascetta, G., Wente, M. N., Felix, K., Giese, N. A., Hinz, U., Di Sebastiano, P., Büchler, M. W., & Friess, H.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2005-09-20
- Volume
- 55
- Issue
- 4
- Pages
- 519-528
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2123837094
- Cited by
- 161
- References
- 1
- FWCI
- 3.25
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vanilloids in pancreatic cancer: potential for chemotherapy and pain management. https://app.cochat.ai/papers/10.1136/gut.2005.073205
- The paper
- Hartel, M., di Mola, F. F., Selvaggi, F., Mascetta, G., Wente, M. N., Felix, K., Giese, N. A., Hinz, U., Di Sebastiano, P., Büchler, M. W., & Friess, H. (2006). Vanilloids in pancreatic cancer: potential for chemotherapy and pain management. Gut. https://doi.org/10.1136/gut.2005.073205
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.